CCL2 and cancer: The obtained results are a good starting point for further studies on the cytoprotective role of IL-6 and MCP-1 against HNSCCs, first in 2D and 3D in vitro models, based on an in vivo model, designing an appropriate anti-cancer therapy combined with radiotherapy.